NMDX HER-2/neu blood test kits

NMDX, a company spun off from now-defunct Nuclea Technologies, is now selling HER-2/neu blood testing kits, acquired from Nuclea. The test measures the presence of HER-2 protein for patients with metastatic breast cancer.